

We design our products to enhance the well being of the patient-while reducing the total outcome costs of healthcare. We are dedicated to developing and delivering better.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. Revenue: 100 to 500 million (USD) Competitors: Unknown. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Type: Company - Public (VIVO) Industry: Biotech & Pharmaceuticals. (NASDAQ: VIVO) who purchased shares between March. Please note that the Barchart Opinion indicators. Barchart's Opinion Trading systems are listed below. Learn more about our Proficiency & Controls business unit. Levi & Korsinky, LLP announces it filed a complaint on behalf of shareholders of Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. In addition, we develop and manufacture a variety of biological and non-biological materials used in proficiency testing programs.

pylori, foodborne diseases and respiratory infections. An IFA test (MERIFLUOR Cryptosporidium/Giardia direct immunofluorescent kit, Meridian Bioscience, Inc.) is probably the most sensitive and specific test for. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in 1.53 Billion All-Cash Transaction. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. The principal executive office of the Company is 3471 River Hills Drive, Cincinnati, Ohio 45244. Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. T his Schedule 13D (this Statement ) relates to the common stock, no par value (the Shares ), of Meridian Bioscience, Inc., a company incorporated in Ohio (the Company ).
